Proteon reports positive results from PRT-201 Phase 2 trial in chronic kidney disease patients
The double-blind, placebo-controlled study randomized 151 patients with either one of two doses of PRT-201, or placebo to evaluate the safety and efficacy of PRT-201 delivery subsequent to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.